Table of contents:

Can I be vaccinated against coronavirus for allergy sufferers and asthmatics?
Can I be vaccinated against coronavirus for allergy sufferers and asthmatics?

Video: Can I be vaccinated against coronavirus for allergy sufferers and asthmatics?

Video: Can I be vaccinated against coronavirus for allergy sufferers and asthmatics?
Video: Respiratory specialist Adrian Chan on impact of COVID-19 on asthma patients 2024, May
Anonim

During the period when mass vaccination began, people suffering from chronic pathologies began to ask questions about the possibility of protecting themselves from infection by introducing an immunizing antigen. We will find out if it is possible to get the coronavirus vaccine for allergy sufferers and asthmatics.

Background to the issue

The media periodically reports on the development of allergic reactions after the administration of the drug to form artificial immunity against COVID-19.

On this occasion, a number of leading experts in the field of allergology, immunology and virology gave many comments, including whether it is possible to vaccinate against the coronavirus for allergy sufferers, asthmatics, patients with other diseases that are chronic or develop as a reaction to third-party provocateurs.

Image
Image

Specialists from the European Medicines Agency, followed by the World Health Organization, gave detailed explanations on this matter:

  1. Anaphylactic shock rarely develops after vaccination. Each drug goes through several stages of testing and is found to be safe.
  2. Negative manifestations after the introduction of the antigen occur only in the presence of individual immunity to the main active ingredient or auxiliary component.
  3. Preventing the likely consequences is easy. Asthmatics and allergy sufferers are advised to be under medical supervision for half an hour after immunization, and those with uncontrolled asthma should be vaccinated in a hospital setting and remain under control for a longer time.

At the same time, representatives of official organizations focused on the lack of study of side effects in individual patients, the need to accumulate knowledge. True, the latter will happen during the long-term use of drugs used for mass vaccination.

Image
Image

Such claims are not particularly credible against the background of reports of a severe allergic reaction in the United States or Europe after injections of Moderna or Pfizer from well-known pharmaceutical companies, which enjoy well-deserved prestige in the global medical community and have an unlimited development budget.

Is it possible to vaccinate against the coronavirus for asthmatics and allergy sufferers, especially after reports that in Mexico and the United States, doctors were in intensive care after being vaccinated with these latest joint developments from German and American scientists? The question remains open.

Image
Image

Situation in Russia

A. Gintsburg, head of the center. Gamaleya, who created the world's first registered vaccine against coronavirus Sputnik-V, commented on the situation and gave clarifications back in December last year. He said under what conditions people suffering from asthma and allergies can be vaccinated with a domestically developed drug:

  • after passing analyzes for C-reactive protein and E-immunoglobulins;
  • not during an exacerbation of the disease;
  • allergy sufferers over 60 years of age on a voluntary basis (monitor their condition).

The basis for vaccination in problem situations should be a decision made by a doctor who is familiar with the clinical picture. When asked about reports of reactions with foreign vaccines, the scientist provided additional clarifications.

Image
Image

Vaccines Moderna or Pfizer are created according to a new principle (this was repeatedly emphasized by its developers). They, unlike Sputnik-V, contain messenger RNA, which is incorporated into a lipid nanoparticle. The development of an immune response at the gene level, in the presence of an RNA virus particle, can cause unpredictable reactions.

More than 40 countries show interest in the Russian vaccine, but so far the production facilities are focused on the needs of the domestic market to ensure the safety of the population of the Russian Federation.

The Sputnik-V vaccine has passed all stages of clinical trials, including in volunteers whose age was above the restrictive barrier indicated in the contraindications. This proved that it is possible to vaccinate against coronavirus for allergy sufferers after the age of 65, but in compliance with the specified safety rules and at their own request.

Recommended: